Cabio Biotech (Wuhan) Co Ltd

688089

Company Profile

  • Business description

    Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.

  • Contact

    No. 999, Gaoxin Avenue
    East Lake New Technology Development Zone
    Hubei Province
    Wuhan430075
    CHN

    T: +86 2767845289

    http://www.cabio.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    508

Stocks News & Analysis

stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?
stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,080.2066.900.83%
CAC 408,028.2890.071.13%
DAX 4022,567.14109.27-0.48%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,632.3389.771.05%
HKSE23,959.98497.332.12%
NASDAQ17,303.01345.44-1.96%
Nikkei 22537,445.20392.101.06%
NZX 50 Index12,245.8220.43-0.17%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,848.9059.200.76%
SSE Composite Index3,412.3253.591.60%

Market Movers